Research Article

PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis

Table 2

(a) Analysis of serum-related indicators in the two groups

TimeGroupNeutrophil ratioCRPAmylaseLipaseAST

BeforeControl group
Observation group
-0.707-0.2071.150.9231.844
0.4830.8370.2560.360.072
AfterControl group
Observation group
1.4882.3040.1542.092.074
0.1420.0270.8780.0410.043

(b) Analysis of serum-related indicators in the two groups

TimeGroupLDHBlood calciumUrea nitrogenTG

BeforeControl group
Observation group
1.296-0.2240.929-1.583
0.20.8230.3570.119
AfterControl group
Observation group
2.32-2.4851.7082.376
0.0240.0160.0930.022

: the difference between the groups was statistically significant.